Back
Barclays PLC Vs. SpringWorks Therapeutics Industry Stock Comparison
Buy
62
BCLYF
Barclays PLC
Last Price:
$3.75
Seasonality Move:
0.26%
Sell
46
SWTX
SpringWorks Therapeutics
Last Price:
$46.16
Seasonality Move:
3.79%
Buy
62
Barclays PLC (BCLYF)
is a Buy
Is Barclays PLC a Buy, Sell or Hold?
-
The current Barclays PLC [BCLYF] share price is $3.75. The Score for BCLYF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BCLYF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy, Sell or Hold?
-
The current SpringWorks Therapeutics [SWTX] share price is $46.18. The Score for SWTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCLYF Stock Price Chart
What is Barclays PLC's stock price today?
-
The Barclays PLC share price today is $3.75The current trend is moderately bullish and BCLYF is experiencing selling pressure, which indicates risk of future bearish movement.
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $46.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BCLYF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 52.81 | Buy |
Chaikin Money Flow: | -64960 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.41 - 3.91) | Buy |
Bollinger Bands (100): | (3.34 - 3.84) | Buy |
SWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.68 | Sell |
Relative Strength Index (14 RSI): | 58.88 | Buy |
Chaikin Money Flow: | 57018164 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.08 - 45.94) | Buy |
Bollinger Bands (100): | (35.82 - 50.36) | Buy |
BCLYF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.7 | Buy |
20-day SMA: | 3.58 | Buy |
50-day SMA: | 3.74 | Buy |
200-day SMA: | 3.28 | Buy |
8-day EMA: | 3.72 | Buy |
20-day EMA: | 3.67 | Buy |
50-day EMA: | 3.66 | Buy |
200-day EMA: | 3.3 | Buy |
SWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.28 | Buy |
20-day SMA: | 40.04 | Buy |
50-day SMA: | 47.44 | Sell |
200-day SMA: | 39.3 | Buy |
8-day EMA: | 42.38 | Buy |
20-day EMA: | 41.85 | Buy |
50-day EMA: | 43.42 | Buy |
200-day EMA: | 40.95 | Buy |
Barclays PLC Earnings Growth & BCLYF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $2.29 per share.
Barclays PLC Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SpringWorks Therapeutics Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |